NCT00963833View on ClinicalTrials.gov

Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis

CompletedOBSERVATIONAL

Enrollment

68

Participants

Timeline

Start Date

December 17, 2009

Primary Completion Date

April 12, 2016

Study Completion Date

September 1, 2016

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Patients under daily life treatment receiving Betaferon according to local product information.

Trial Locations (6)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY